NSEPress Release5d ago · 5 Aug 2026, 10:49 pm

Press Release

Godavari Biorefineries Limited · GODAVARIB

✦ AI Summary▲ PositiveResults

Godavari Biorefineries Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a 9.0% YoY EBITDA growth and a 53% YoY increase in bio-based chemicals strength. The company has also secured an Indian patent for a cost-effective process to manufacture branched alcohols and filed with the CDSCO to initiate preliminary efficacy trials for its lead anti-cancer molecule.

Analysis Scores

Earnings Impact8/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact9/10
Market Sentiment8/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Godavari Biorefineries Limited has informed the Exchange regarding a press release dated August 05, 2026, titled "Unaudited Financial Results for the Q1FY27".

Attachments (1)

📄

GODAVARIBIO_05082026224909_Press_Release_June_2026.pdf

pdf

Download →
View document text
Dated: August 05, 2026 The Manager The Manager Listing Department Listing Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Tower, Bandra Kurla Complex, Bandra (E), Dalal Street Mumbai – 400 051 Mumbai-400001 Script Symbol: GODAVARIB Script Code:544279 Dear Sir / Madam, Sub: Submission of Press Release on unaudited financial results for the Quarter Ended June 30, 2026 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release being issued by the Company with respect to the Unaudited Financial Results for the quarter ended June 30, 2026, as approved by the Board of Directors at its meeting held today. The aforesaid Press Release is also being made available on the website of the Company. Kindly take the same on record Thanking you, Yours faithfully For Godavari Biorefineries Limited Manoj Jain Company Secretary & Compliance O(cid:431)icer Membership No. F-7998 Godavari Biorefineries Ltd. Investor Release Godavari Biorefineries Limited Reports Q1 FY27 Results Resilient revenue growth amid industry headwinds Mumbai, 05th August 2026 – Godavari Biorefineries Ltd., one of the largest producers of ethanol and a pioneer in manufacturing bio-based specialty chemicals in India, announced its Financial Results for the quarter ended on June30, 2026. Q1 FY27 Key Snapshot Bio-based Financial Ethanol Drug Discovery Chemicals Strength 53% ₹13.9 Cr 200 KLPD Japanese Patent EBITDA Growth YoY Finance costs Grain-based distillery Granted for Novel commissioned Anti-cancer Molecule 9.0% YoY 11.4% 9.0% YoY 800 KLPD CDSCO Application EBITDA Margin (₹15.3 crore in Q1 TotalCapacity Filed for Preliminary vs 8.9% in Q1 FY26 FY26) Efficacy Trials for our lead novel anti-cancer molecule Q1 FY27 Financial Performance (Consolidated) TOTAL INCOME EBITDA* PAT Rs. 559.9 Cr Rs. 2.6 Cr Rs. (19.3) Cr Particulars (Rs. Cr) Q1 FY27 Q1 FY26 Q4 FY26 FY26 Total Income 559.9 534.0 570.0 2,000.2 EBITDA^ 2.6 6.5 92.1 139.3 PAT (19.3) (16.0) 52.9 3.5 * EBIDTA Includes Other Income Godavari Biorefineries Ltd. Investor Release Segment Revenue Mix Revenue from Operations Revenue from Operations Rs. 557.9 Crores Rs. 533.2Crores 2% 2% 28% 33% Q1 FY27 Q1 FY26 30% 26% Sugar & Cogeneration Bio-Based Chemicals Ethanol Unallocated Commenting on the Results, Shri Samir Somaiya, CMD said, “Q1 FY27 marked an important quarter in strengthening Godavari Biorefineries' integrated platform through strategic execution and operational milestones. During the quarter, we successfully commissioned our 200 KLPD grain-based distillery at Sameerwadi, increasing our total ethanol capacity to 800 KLPD and significantly enhancing our feedstock flexibility. This investment strengthens our ability to optimize operations across varying market conditions while creating a more resilient and future-ready ethanol business. Our Bio-based Chemicals business delivered another strong quarter, with robust revenue growth, healthy margin expansion and improved profitability, reflecting the benefits of our debottlenecking initiatives and continued focus on higher-value specialty products. During the quarter, we also secured an Indian patent for a cost-effective process to manufacture branched alcohols, reflecting our continued focus on developing efficient and differentiated technologies. Further advancing our innovation pipeline, we filed with the CDSCO to initiate preliminary efficacy trials for our lead anti-cancer molecule targeting Triple Negative Breast Cancer, with trials expected to commence from Q3 FY27, subject to regulatory approvals. This marks a significant milestone in translating our R&D efforts into potential clinical applications. As we look ahead, our strategic priorities remain centered on expanding our high-value Bio-based Chemicals portfolio, strengthening strategic partnerships and commercialising innovation-led products. We are equally focused on enhancing ethanol fungibility to capitalise on India's evolving biofuel landscape, alongside sustained efforts in R&D and product innovation. These initiatives, supported by our integrated bio-refinery platform, position us well to deliver sustainable long-term growth and value creation.” Godavari Biorefineries Ltd. Investor Release About Godavari Biorefineries Ltd Godavari Biorefineries Ltd is one of the largest producers of ethanol and a pioneer in manufacturing bio- based specialty chemicals in India. It’s diversified product portfolio comprises bio-based chemicals, sugar, rectified spirits, ethanol, other grades of alcohol and power. It is the only company in India to have such a vast portfolio of bio-based products. Investor Relations: MUFG Intime India Pvt. Company Ltd. Name: Mr. Ashish Sinha – AGM IR & Finance Name: Ms. Prachi Ambre / Mr. Irfan Raeen Email: prachi.ambre@in.mpms.mufg.com / Email: investorrelations@somaiya.com irfan.raeen@in.mpms.mufg.com Link CIN: L67120MH1956PLC009707 Meeting Request Link https://godavaribiorefineries.com/ Website: https://in.mpms.mufg.com/ Safe Harbor Anyforward-lookingstatementsaboutexpectedfutureevents,financialandoperatingresultsoftheCompanyare based on certain assumptions which the Company does not guarantee the fulfilment of. Past performance also should not be simply extrapolatedinto the future.These statements are subjecttorisks anduncertainties.Actual resultsmightdiffersubstantiallyormateriallyfromthoseexpressedorimplied.Importantdevelopmentsthatcould affect the Company’s operations include a downtrend in the industry, global or domestic or both, significant changes in political and economic environment in India or key markets abroad, tax laws, litigation, labour relations, exchange rate fluctuations, technological changes, investment and business income, cash flow projections,interest, and other costs. The Company does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date thereof.